Trademark Overview
On Monday, February 5, 2024, a trademark application was filed for ELASTATHERAPY with the United States Patent and Trademark Office. The USPTO has given the ELASTATHERAPY trademark a serial number of 98391875. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, February 5, 2024. This trademark is owned by Allergan Pharmaceuticals International Limited. The ELASTATHERAPY trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations and compositions for the treatment of acquired and congenital skin conditions and acquired and congenital skin diseases; biochemical and biological substances for medical use, namely, forms of protein and polysaccharide preparations for the treatment of acquired and congenital skin conditions and acquired and congenital skin diseases; drug delivery preparations for medical use, namely, forms of protein and polysaccharide preparations used for the controlled release of pharmaceuticals; medical preparations, namely, medicated skin care preparations